Podcast Q&A: Medicare and Medicaid Services Market Pricing
Airdate: Thursday, July 6, 2023 Season: 2 Episode: 5
Guests: Mark McCoy, Earlene Biggs, Bruce Capobianco, Tanja Obradovic, Ki Park, Nancy Risebrough
Sponsor: ICON
In this episode of tHEORetically Speaking, join ICON experts Mark McCoy, Dr. Earlene Biggs, Bruce Capobianco, Dr. Tanja Obradovic, Ki Park, and Nancy Risebrough as they answer questions on the Centers for Medicare and Medicaid Services’ negotiations on the fair market prices for Medicare Part D products.
Associated Webinar: Medicare Part D: Price Negotiation Panel Discussion
Similar Podcasts
Podcast Q&A: Clinical Outcomes Assessments and Training
In this episode of tHEORetically Speaking, join Kelly Lipman, Heather Dickerson, and Ryan Murphy from ICON, who answer questions from a recent webinar on the dynamic landscape of clinical outcomes assessments, examining their historical significance, current uses and best practices, and making a case for greater standardization in their implementation.
Podcast Q&A: Clinical Outcome Assessment (COA) Translations
In this episode of tHEORetically Speaking, join Christelle Giroudet, MA and Ana Alvarez, MA, COA Linguistic Validation Leaders with ICON, as they highlight the importance of Linguistic Validation and how equivalence should be a key focus during the development of Clinical Outcome Assessment translations.
Podcast Q&A: Exploring Social Media Data in Different Contexts
Experts answer questions on how to collect, use, analyze, and interpret social media data in different contexts.
Additional Content From ICON
Strategies to Optimize Commercialization of Oncology Treatments for Younger Adults
Watch this webinar on addressing early onset cancer through strategic trial design, targeted launch indications, and increased trial access to speed up the delivery of impactful treatments.
Navigating the Clinical Outcomes Maze: An Overview of Clinical Outcomes Assessments and Why Training Matters
This webinar delves into the dynamic landscape of COAs, examining their historical use and significance, current uses and best practices, and making a case for greater standardization in their implementation.
Minimizing the Impact of Cross-Cultural Differences in COA Translations
ICON's COA Linguistic Validation Leaders highlight the importance of Linguistic Validation and how equivalence should be a key focus during the development of Clinical Outcome Assessment translations.